Sonera develops sensing technology that non-invasively detects magnetic signals generated by neural activity to make brain and muscle activity easy to measure. Its first product is the S1 chip for muscle sensing, designed to enable a new class of consumer wearables and experiences based on muscle activity without direct skin contact. The S1 approach measures magnetic fields from electrical currents tied to neural activity, aiming to deliver high-fidelity signals for use cases such as advanced prosthetics control, continuous neuromuscular monitoring, biomarker discovery, and sports performance tracking. The company positions neural data as a broadly useful physiological signal—similar to heart rate or temperature—for personal computing, smart apparel, healthcare, and neurotherapeutics. Sonera is led by CEO Nishita Deka and intends to use new funding to advance accessibility of neural data across these applications. Financially, the company has raised $11M in this Seed round, bringing total funding to $20M.

Total raised

$11M

Funding rounds

1

Latest round

Seed

Latest activity

Sep 2023